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Research Paper
Geographic disparities persist despite
decline in mortality from IHD in
California’s Central Valley 1999–2014
Ralph Spada1 , Nicholas Spada2 and Hyosim Seon-Spada3
Abstract
Background: Nationally, ischemic heart disease mortality has declined significantly due to advancements in managing
traditional risk factors of hypertension, diabetes, hyperlipidemia, smoking, and obesity and acute intervention. However
geographic disparities persist that may, in part, be attributed to environmental effects.
Methods: Ischemic heart disease age-adjusted mortality were obtained from the CDC database for years 1999 through
2014 by county, gender, race, and Hispanic origin for the Central Valley of California.
Results: There was an increase in mortality from north to south of 14.9 (95% CI: 8.0–21.9, p value <0.0001) in time
period 1, 7.9 (95% CI: 0.8–15, p value <0.05) in time period 2, and 9.2 (95% CI: 4.0–14.3, p value <0.001) in time period
3. In time period 1, the ambient particulate matter 2.5 micrometers (PM2.5) level increased from north to south by
0.84 mg/m3 (95% CI: 0.71–0.96), in time period 2 there was a 0.87 mg/m3 increase (95% CI: 0.74–1.0), and a 1.0mg/m3
increase in time period 3 (95% CI: 0.87–1.1). PM2.5 level was correlated to IHD mortality in all time periods (Period 1
r2¼ 0.46, p¼ 0.0001; Period 2, r2¼ 0.34, p¼ 0.008; Period 3 r2¼ 0.51, p value <0.0001).
Conclusion: Continued declines in ischemic heart disease mortality will depend on the concerted efforts of clinicians in
continuing management of the traditional risk factors with appropriate medication use, acute interventions for coronary
syndromes, the necessity of patient self-management of high risk behaviors associated with smoking and obesity, and the
development of coordinated actions with policy makers to reduce environmental exposure in their respective
communities.
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Introduction
Ischemic heart disease (IHD) is a common and costly
condition that is showing a steady decline thought to be
explained by a decrease in coronary atherosclerosis due
to improved primary and secondary prevention and
acute intervention.1–3 The American Heart
Association Executive Summary for 2016 noted a reduc-
tion of 28.8% from 2003 to 2013; however, it still
accounted for 30.8% of all deaths, or 1 of every 3 in
2013.4 National trends in mortality have shown a
steady decline; however, rates still show geographic dis-
parities. Vaughan estimated age-adjusted mortality of
disease of the heart for 3099 United States (US) counties
between 1973 and 2010 and found significant differences
in decline of mortality between races, gender, and
geography. They suggested that differences in diffusion
of risk management and acute intervention efforts were
the cause.5 Gillum et al. analyzed age-adjusted coronary
heart disease death rates comparing European
Americans to non-Hispanic African-Americans in the
US between 1999 and 2007. They found persistent
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disparities in the level and rate of decline between the
two races and by geography. They attributed the differ-
ences to the classic risk factors of a diet high in saturated
fats, elevated serum cholesterol, blood pressure, diabe-
tes, and smoking.6 Leigh et al. reviewed the recent liter-
ature in ethnic minorities coronary heart disease
disparities and found much of the differences to be
attributed to the persistent gap in socioeconomic
status and health care system-level factors.7 In the
Harvard Six Cities study, a study of a cohort of
adults followed prospectively beginning in 1974 for
14–16 years, Dockery et al. and later in a follow-up
extension, Laden et al. found that cardiovascular dis-
ease mortality was positively associated with ambient
particulate matter of size  2.5mg/m3 (PM2.5) air pollu-
tion.8,9 Pope et al. corroborated this finding in the
American Cancer Society study of a cohort of 552,138
adults with a seven-year follow-up who were assessed
for risk of death from cardiopulmonary disease in
151 USmetropolitan areas. They found that an increase
of PM2.5 of 10 mg/m
3 was associated with an 8–18%
increase in CVD mortality.10 More recently Di et al.
estimated the risk of over 60 million Medicare benefi-
ciaries and found significant adverse effects related to air
pollution exposure, particularly in racial minorities and
those of low income.11
The Clean Air Act, first established in 1970, and
amended in 1990, identified two types of ambient air
quality standards. Primary standards provide public
health protection, including the health of “sensitive”
populations, and secondary standards that are related
to decreased visibility and damage to animals, vegeta-
tion and buildings. Since 2012 the standard for PM2.5
has been an average annual level of 12.0 mg/m3 for pri-
mary and 15.0 mg/m3 for secondary (https://www.epa.
gov/criteria-air-pollutants/naaqs-table). The level for
PM10 was less than 50 mg/m
3 until it was revoked by
the United States Environmental Protection Agency
(EPA) in 2006.12
California has ranked in the upper half compared to
the other states though IHD rates have also declined
considerably. Despite these achievements, the Central
Valley has historically had higher rates compared to
the rest of the state, for reasons which have not been
entirely explained.13 It has been suggested that there is
a gradient of increasing ischemic heart disease from
north to south due to environmental exposures.
Although also declining, the PM levels have been
above the national standards.
The Central Valley of California is a rich and fertile
agricultural and industrial area. It has unique geo-
graphic and climate qualities that may contribute to
the observed trends in ischemic heart disease mortality.
Reports from the California Department of Public
Health on the burden of cardiovascular disease noted
in 1994,14 and later in 200713 a geographic trend in the
Central Valley. Cahill et al. noted a relationship with
ambient air particulate matter that may have, in part,
explained this observation.15 This study was designed
to estimate the relative mortality risks and ambient air
pollution levels in this area.
Methods
Age-adjustedmortality data from ischemic heart disease
(International Classification of Disease 10th (ICD-10)
codes I20-I25), grouped by county, gender, race, and
Hispanic origin were accessed from the National Vital
Statistics System (NVSS) database from years 1999
through 2014.16 Race was classified as Caucasian,
African-American, Asian-American, Hispanic (as iden-
tified by Hispanic or Latino origin), and American-
Indian/Alaska Native. Age-adjusted death rates were
computed for persons 45 and older per 100,000 using
the 2000 US standard population. Following NVSS
policy, death rates reported to be less than 20 were
reported as unreliable and thus missing. Comorbidity
data were accessed from the California Health
Information Survey (CHIS) database.17 Smoking rate
data were also obtained from the California Tobacco
Survey database website. Population statistics were
from the California Department of Finance database
for 2010. The ambient PM2.5 average annual levels
were obtained from the Environmental Protection
Agency’s Data Mart (http://aqsdr1.epa.gov/aqsweb/
aqstmp/airdata/download_files.html#1999-2014). The
years of 1999 to 2014 were divided into three 5-year
periods, 1999–2004, 2005–2009, and 2010–2014.
Statistical analysis used correlation, ANOVA, and
Bartlett’s test for equal variances functions of STATA
(STATA Corp., version 13, College Station, TX).
Study population
California adults from age 45 and older served as the
comparison group and adults from age 45 and older in
the respective counties were the study group. This was
an ecological study. The thirteen counties (Shasta,
Butte, Sutter, Placer, Sacramento, Yolo, San Joaquin,
Stanislaus, Madera, Fresno, Kings, Tulare, Kern) in the
Central Valley have been collectively called the Transect
counties, i.e., a narrow section through a natural feature
along which observations are made. California Central
Valley racial distribution is heavier in Caucasian (54%–
87%) and Hispanic (8%–61%), with much fewer
African-Americans (2%–10%), Asian-Americans
(3%–14%), and American-Indian/Alaska Native (AI/
AN, <1%) (CA Dept. of Finance, http://www.dof.ca.
gov/research/demographic/state_census_data_center/
census_2010/#SF2). The northern Transect counties are
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predominately Caucasian (Shasta, 87%, Butte, 82%,
Sutter, 61%, Placer, 84%, Sacramento, 57%, Yolo,
63%, San Joaquin, 51%, Stanislaus, 66%, Madera,
63%, Fresno, 55%, Kings, 54%, Tulare, 60%, and
Kern, 60%)which allowed controlling for race by study-
ing IHD rates in Caucasian. In the counties with the
lowest percent Caucasian, they were predominantly
Hispanic (50%–60%).
The CDC transitioned cause of death ICD codes to
ICD-10 starting in 1999. The codes I20.0–I25.9 incor-
porate ischemic heart disease. ICD codes representing
acute ischemic heart disease were used 36% of the time
(I21.9, AMI, unspecified) and those for chronic disease
were used 64% (I25.0, ASCVD, so described, 19.1%,
I25.1, ASCVD, 39.7%, I25.5, ischemic cardiomyopa-
thy, 4.3%, and I25.9, chronic ischemic heart disease,
unspecified, 2.6%).
Average annual age-adjusted death rates were
compared by gender and race. Because of the heavy
distribution towards White and Hispanics in most
counties, and primarily Caucasian in the northern
counties, race adjusted rates were calculated and com-
pared only for the Caucasian racial group. Because of
the consistent death rate of women being two-thirds
that of men, trend analysis focused on Caucasian men.
Results
California, in general, had a rate of 487 (SD, 179)
deaths per 100,000 during the first time period, 486.6
(SD, 179) in the second, and 293.8 (SD, 79) in the third,
a 40% decline. The total population for the Transect
counties was 1,921,144 in Period 1, 1,875,589 in Period
2, and 2,070,574 in Period 3 which represented approx-
imately 13% of the total California population. The
mean population for each of the Transect counties
studied was 147,780 in Period 1, 144,276 in Period 2,
and 159,274 in Period 3. The mean IHD deaths rates
for all races 560 (SD, 203), 442 (SD, 173) (21%
decline), 345 (SD, 131) (38% decline), all men 678.4
(SD, 181), 539 (SD, 154) (21% decline), 431.8 (SD,
109) (36% decline), all women 437.4 (SD, 143), 342.8
(SD, 129) (22% decline), 253.4 (SD, 79) (43% decline),
Caucasian men 694.5 (SD, 127), 559.9 (SD, 110) (19%
decline), 466.4 (SD, 84) (32.8% decline), and Caucasian
men 433.4 (SD, 102), 343.8 (SD, 85) (21% decline),
258.7 (SD, 65) (61% decline) declined steadily with
the larger reduction between the second and third peri-
ods. Women consistently had death rates between 30%
and 40% less than their men counterparts. African-
American men had the highest rate in each period
869 (SD, 223), 731 (SD, 168) (16% reduction) and
523.4 (SD, 119) (40% reduction) and had comparable
reductions. African-American women also had the
highest rates of the women 634.6 (SD, 147), 526.4
(SD, 149) (16% reduction), and 332.3 (SD, 66) (48%
reduction) but also some of the highest reduction.
Hispanic men had rates less than their Caucasian coun-
terparts 590.8 (SD, 155), 428.4 (SD, 92) (28% reduc-
tion), and 358.1 (SD, 68) (39% reduction) but with a
similar reduction in mortality. Hispanic women 382.7
(SD, 104), 278.8 (SD, 84) (28% reduction), and 233.1
(SD, 72) (40% reduction) Asian-American men were
similar to Hispanic men 559.5 (SD, 153), 435.3 (SD,
125) (22% reduction), and 349.5 (SD, 108) (38% reduc-
tion) followed by Asian-American women who had the
lowest rates, 293.1 (SD, 55), 221.6 (SD, 59) (25%
reduction), 196.1 (SD, 94) (33% reduction). For the
counties with a significant Hispanic population, the
total IHD mortality rate would be lower if not con-
trolled for race.
Towards the third period, although African-
American men still had higher IHD mortality rates,
they approached Caucasian men’s rates (25% higher
IHD rate for African-American compared to
Caucasians in Period 1, 31% in Period 2, and 12% in
Period 3). Hispanic and Asian-American men both were
20% lower than Caucasian men. African-American
women were much higher than their Caucasian counter-
parts in Period 1, but then also approached their
Caucasian counterparts (46% higher in Period 1, 53%
in Period 2, and 28% higher in Period 3). Hispanic and
Asian-American women were lower than their
Caucasian counterparts by approximately 10% to 30%.
For the three time periods, there was a significant and
consistent decline in rates from IHD in the Transect
Counties; however, a trend of increasing death rates
from north to south was evident (Figures 1 and 2).
The notation “distance from north” indicates that the
counties are presented in a north to south ordering to
highlight the geographical nature of the data.
The mean reduction in IHD mortality was 114.6
deaths per time period in the Central Valley (95% CI:
132.8 to 96.4). There was an increase in mortality
from north to south of 14.9 (95% CI: 8.0–21.9) in time
period 1, 7.9 (95% CI: 0.8–15) in time period 2, and 9.2
(95% CI: 4.0–14.3) in time period 3.
The traditional risk factors of hypertension, diabe-
tes, smoking and obesity were compared (Figure 3).
Hypertension was present in 24.3% (SD, 1.9) in first
period, 28.3% (SD, 2.9) in second, and 29.5% (SD, 4.9)
in third, p value <0.001 for trend. It increased per time
period by 2.4% (95% CI: 1.8–3.1, p value <0.001), it
increased from north to south by 0.3% in Period 2
(95% CI: 0.1–0.17, p value not significant (ns)) in
Period 1, it dropped by 0.3% in Period 2 (95% CI:
0.5–0.07, p value <0.01), and by the same in Period 3
(95% CI: 0.7–0.01, p value ns). Diabetes was present
in 7.9% (SD, 1.3) in Period 1, 8.5% (SD, 1.7) in Period
2, and 8.9% (SD, 3.6) in Period 3, p value <0.0001 for
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trend. It increased 0.9% per time period (95% CI:
0.52–1.4, p value <0.0001 for trend). It increased
from north to south in Period 1 by 0.07 (SD, 0.05)
(95% CI: 0.02–0.17, p value ns), 0.3% (SD, 0.04) in
Period 2 (95% CI: 0.2–0.4, p value <0.0001), and
dropped 0.06% (SD, 0.13) in Period 3 (95% CI:
0.03–0.2, p value ns). Hyperlipidemia was only avail-
able for the second period, the mean was 21.9 (SD, 0.6)
and it dropped from north to south by 0.2% (95%
CI: 0.3–0.002, p value <0.05).
Smoking and obesity were reviewed (Figure 4).
Smoking was present in 31.9% (SD, 2.7) in Period 1,
30.3% (SD, 6.4) in Period 2 and 29.5% (SD, 5.7)
Period 3, p value <0.0001 for trend. It dropped by
time period by 1.6% (SD, 0.5) (95% CI: 2.5–0.07,
p value <0.001). It increased from north to south by
0.3 (SD, 0.1) (95% CI: 0.1–0.5, p value <005) in Period
1, it dropped by 0.02 (SD, 0.2) (95% CI: 0.05–0.4, p
value ns), and increased by 1% (SD, 0.2) (95% CI: 0.7–
1.3, p value <0.001). Obesity was present 23.9% (SD,
2.9) in Period 1, 28.1% (SD, 3.4) in Period 2 and 29%
(SD, 6.2) in Period 3, p value <0.001 for trend. In
Period 1 it increased from north to south by 2.9%
(SD, 0.4) (95% CI: 2.1–3.7, p value <0.001), by 0.6%
(SD, 0.1) in Period 2 (95% CI: 0.4–0.07, p value
<0.001), and by 0.8% (SD, 0.2) (95% CI: 0.5–1.2, p
value <0.001).
Hypertension correlated with diabetes modestly
(r¼ 0.45, p value <0.001), diabetes and smoking corre-
lated better (0.57 and 0.60 respectively, p value
<0.001). There was no significant correlation between
hypertension, smoking, or obesity.
Distance from north, PM10 and PM2.5 annual aver-
ages were studied (Figure 5).
There was a reduction of the level of PM10 of
2.5 mg/m3 (95% CI: 4.1–0.9) over each time period.
In time period 1, the PM10 level increased from north
to south by 2.2mg/m3 (95% CI: 2.0–2.5), in time period
2 there was a 2.3mg/m3 increase (95% CI: 2.1–2.5), and
a 2.3 mg/m3 increase in time period 3 (95% CI: 2.0–2.5).
PM10 level was correlated to IHD mortality in time
periods 1 and 3 (Period 1: r¼ 0.29, p¼ 0.01; Period 2:
r¼ 0.22, p value ns; Period 3: r¼ 0.5, p value <0.0001).
There was a reduction of the level of PM2.5 of 2.1 mg/m
3
(95% CI: 2.8–1.4) over each time period. In time
period 1, the PM2.5 level increased from north to
south by 0.84 mg/m3 (95% CI: 0.71–0.96), in time
period 2 there was a 0.87 mg/m3 increase (95% CI:
0.74–1.0), and a 1.0 mg/m3 increase in time period 3
(95% CI: 0.87–1.1). PM2.5 level was correlated to
IHD mortality in all time periods (Period 1: r¼ 0.46,
p¼ 0.0001; Period 2: r¼ 0.34, p¼ 0.008; Period 3:
r¼ 0.51, p value <0.0001).
Counties were compared by population size, the
larger counties (those greater than 200,000) had a sig-
nificantly higher IHD mortality rate compared to the
smaller counties (less than 50,000) (775 vs. 659.2 in
Period 1, 610 vs. 510 in Period 2, and 485.5 vs. 433.5
in Period 3, all p values significant at 0.05 or better).
Comparing the northern counties (Shasta, Butte,
Sutter, Placer) with the southern counties (Fresno,
Kings, Tulare, Kern) demonstrated a significant greater
IHD mortality rate in the larger counties (IHD rate
629.1 vs. 750.2 for Period 1, 525.1 vs. 582.6 for
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Figure 1. Ischemic heart disease mortality rate of Caucasian males in the California Central Valley 1999–2014 by county arranged
north to south. Shasta County is at the most northern end and Kern County is at the southern end.
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Figure 2. Ischemic heart disease mortality rates in Caucasian males arranged by distance from the most northerly county to the
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Period 2, and 433.2 vs. 501.2 for Period 3, all p values
significant at 0.05 or better).
Discussion
The results of this population-based study demonstrate
that the persistence in IHD mortality disparities may be
due to the relatively increased prevalence in smoking,
obesity, and environmental exposures in the southern
counties as compared the northern counties. The con-
sistent decline across race and gender suggests equal
access and quality of care regarding primary and sec-
ondary management of risk factors and acute interven-
tions, while the demonstration of a geographic trend
suggests environmental factors at play. Jolly et al. stud-
ied the rates of cardiac procedures in American-Indian/
Alaska Native population in California and found
comparable rates.18
Clinicians have more control of the management of
hypertension and hyperlipidemia through medical
management and relatively modest control over diabe-
tes due to the difficulty in assuring compliance with diet
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Figure 4. Rates of smoking and obesity in each county arranged north to south by time period.
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Hypertension, Diabetes and Hyperlipidemia
by Distance From North
 HTN  Diabetes  HLP
Figure 3. Rates of hypertension, diabetes and hyperlipidemia in each county arranged north to south by time period.
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and activity. Smoking and obesity less so, though with
persistent and repeated encouragement, results can be
rewarding. Yang et al. studied the trends in cardiovas-
cular health metrics which include not smoking, phys-
ically active, blood glucose and cholesterol levels,
weight and eating a healthy diet and noted a significant
reduction in IHD mortality in those who adhered to
more of the metrics.19
Unlike the traditional risk factors whose pathophys-
iologic effects are well known, the role of ambient par-
ticulate matter is less so. Mechanisms proposed are
activation of the pulmonary receptors resulting in auto-
nomic nervous system imbalance and the development
of rhythm disturbances, induction of pulmonary and
systemic inflammation, and introduction of the par-
ticles to the systemic circulation.20 Interestingly, this
seems to be more strongly correlated with IHD than
stroke.15 Evidence is accumulating regarding the role of
specific components of ambient air pollution and
IHD.21–23 Although the PM10 levels for the counties
of the Central Valley are well below the 2006 standard,
the southern counties continue to be significantly above
the standard for PM2.5. PM2.5 has been accepted as an
important contributor to cardiovascular morbidity and
mortality.24
Clinicians need to partner with community leaders
in order to make an impact on environmental effects,
as seen in Utah.25 The American College of Physicians
has addressed this in their recent position paper on the
effects of climate change on health.26 Also, though the
most current CVD risk calculations have been validat-
ed, it may be necessary to add a geographic or envi-
ronmental modifier to allow attainment of mortality
decline parity.27 Di et al. were able to stratify the
adverse effects of air pollution at the zip code level,
adding this to the current CVD risk calculators
would identify populations at increased risk and pro-
vide an opportunity to be treated with aspirin and
lipid-lowering agents.
The strengths of the study are the length of time
frame allowing long-term trends to be studied. The
limitations of the study are those common to ecological
studies, in that associations may be identified but
no causal associations may be estimated. Data for
hypertension, diabetes, smoking and obesity would
be more accurate if from cohort or case–control
databases. Mortality rates based on validated events
would allow stronger confidence than those from
death certificates.
Conclusion
Continued declines in ischemic heart disease mortality
will depend on the concerted efforts of clinicians in
continuing management of the traditional risk factors
(hypertension, diabetes, and hyperlipidemia) with
appropriate medication use, the necessity of patient
self-management of high risk behaviors associated
with smoking and obesity (personal pollution), and
the development of coordinated actions with policy-
makers to reduce environmental exposure in their
respective communities.
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Figure 5. PM10 and PM2.5 concentration levels arranged by county from north to south and by time periods.
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